Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 18 min 15 sec ago

Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer

Tue, 07/29/2014 - 15:10
OXFORD, England, July 29, 2014 -- (Healthcare Sales & Marketing Network) --Glide Pharmaceutical Technologies Ltd (Glide Pharma) today announced that it has taken an exclusive worldwide licence to an innovative prostate cancer diagnostic technology from FS...
Biopharmaceuticals, Diagnostics, Oncology, Licensing
Glide Pharma, FScan, prostate cancer

Owens and Minor Implements Management Succession Plan

Tue, 07/29/2014 - 15:06
President & COO James Bierman Named President & CEO, Effective September 1st; Craig Smith to Serve as Executive Chairman RICHMOND, Va.--(Healthcare Sales & Marketing Network)--Owens & Minor, Inc. (OMI), a leading healthcare logistics company, today ann...
Devices, Distribution, Personnel
Owens & Minor

Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test for Group A Strep

Mon, 07/28/2014 - 15:54
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received clearance fro...
Diagnostics, FDA
Quidel, AmpliVue, Streptococcus

New Chlamydia and Gonorrhea Assays on the BD Viper(TM) LT System Receive FDA 510k Clearance

Mon, 07/28/2014 - 15:51
Assays bring an innovative solution to microbiology and molecular labs BALTIMORE, July 28, 2014 -- (Healthcare Sales & Marketing Network) -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), (BDX) announced today it has received 510(k) c...
Diagnostics, FDA
BD , ProbeTec, Chlamydia, Gonorrhea

Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer

Mon, 07/28/2014 - 14:23
Latest Data Sweep from a 285 Patient Subgroup Shows An Impressive 57% Improvement in Overall Survival Data Continues to Validate Phase III OPTIMA Study Design LAWRENCEVILLE, N.J., July 28, 2014 -- (Healthcare Sales & Marketing Network) -- Celsion Corp...
Biopharmaceuticals, Oncology
Celsion, HEAT Study, ThermoDox

Teleflex Announces European Launch of LMA SureSeal(TM) PreCurved

Mon, 07/28/2014 - 13:11
WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, has announced the European launch of the CE marked LMA SureSeal™ PreCurved. The LMA SureSeal Pre...
Devices, Product Launch
Teleflex, LMA, SureSeal, PreCurved

Aqua Pharmaceuticals, LLC Announces the U.S. Food and Drug Administration (FDA) Approval of ACTICLATE(TM) (doxycycline hyclate USP) Tablets, 150 mg and 75 mg

Mon, 07/28/2014 - 13:08
WEST CHESTER, Pa.--(Healthcare Sales & Marketing Network)--West Chester-based Aqua Pharmaceuticals, an Almirall company, today announces the U.S. Food and Drug Administration (FDA) approval of the NDA for ACTICLATE™ (doxycycline hyclate USP) Tablets, 150 m...
Biopharmaceuticals, FDA
Aqua Pharmaceuticals, Almirall, ACTICLATE, doxycycline hyclate

Aurora Spine Announces First Surgery Using Zip Graft(TM) Bone Dowel

Fri, 07/25/2014 - 21:11
CARLSBAD, CALIFORNIA--(Healthcare Sales & Marketing Network) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the first U.S. surgery using the ZIP Graft ™ pre-packaged sterile bone dowel. The surgery was performed at Madison County Hospital in ...
Devices, Neurosurgery, Orthopaedic
Aurora Spine, ZIP Graft, bone dowel, spine surgery

European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval of IMBRUVICA(R) (ibrutinib) for Treatment of Two Blood Cancers

Fri, 07/25/2014 - 13:15
SUNNYVALE, Calif., July 25, 2014 -- (Healthcare Sales & Marketing Network) -- Pharmacyclics, Inc. (PCYC) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recomm...
Biopharmaceuticals, Oncology, Regulatory
Pharmacyclics, Janssen, IMBRUVICA, ibrutinib

Guided Therapeutics Files PMA Amendment with FDA for LuViva(R) Advanced Cervical Scan

Fri, 07/25/2014 - 13:09
NORCROSS, Ga.--(Healthcare Sales & Marketing Network)--Guided Therapeutics, Inc. (GTHP) (GTHP) today announced that it has filed an amendment to its premarket approval (PMA) application with the U.S. Food and Drug Administration (FDA) for the LuViva® A...
Devices, Diagnostics, FDA
Guided Therapeutics, LuViva, Advanced Cervical Scan, spectroscopy

Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR(R) (sorafenib) in Patients with Advanced Breast Cancer

Fri, 07/25/2014 - 13:01
WHIPPANY, N.J. and SOUTH SAN FRANCISCO, Calif., July 25, 2014 -- (Healthcare Sales & Marketing Network) -- Bayer HealthCare and Onyx Pharmaceuticals Inc., an Amgen subsidiary (AMGN), today announced that an investigational Phase 3 trial of NEXAVAR® (s...
Biopharmaceuticals, Oncology
Bayer HealthCare, Onyx Pharmaceuticals, Amgen, NEXAVAR, sorafenib, breast cancer

Bioheart Announces World's First Combination Stem Cell Treatment

Thu, 07/24/2014 - 14:59
SUNRISE, FL--(Healthcare Sales & Marketing Network) - Bioheart, Inc. (OTCQB: BHRT) announced today that it has completed the world's first combination stem cell treatment with Magnum Cell Therapies (Magnum) in Honduras. A patient with congestive heart fai...
Regenerative Medicine, Cardiology
Bioheart, AdipoCell, MyoCell, stem cell, heart failure

Philips receives FDA 510(k) clearance for its innovative ultra mobile VISIQ ultrasound system

Thu, 07/24/2014 - 14:53
Transducer-plus-tablet display delivers excellent image quality, making ultrasound available anytime, in a wide range of clinical environments for OB patients ANDOVER, Mass., July 24, 2014 -- (Healthcare Sales & Marketing Network) -- Royal Philips (NYS...
Devices, FDA
Royal Philips, VISIQ, ultrasound, imaging

Boston Scientific Receives CE Mark For Agent(TM) Drug-Coated Balloon

Thu, 07/24/2014 - 14:48
Innovative Technology Adds To Company's Leading Portfolio of Treatment Options for Coronary Artery Disease MARLBOROUGH, Mass., July 23, 2014 -- (Healthcare Sales & Marketing Network) -- Continuing to advance the development of innovative treatment opti...
Devices, Interventional Cardiology, Regulatory
Boston Scientific, Paclitaxel, drug-coated balloon, PTCA, balloon catheter

FDA Approves Eagle Pharmaceuticals’ Ryanodex(R) for the Treatment of Malignant Hyperthermia

Wed, 07/23/2014 - 13:08
Novel Antidote Enables Quicker Response to Inherited Life-Threatening Condition Orphan Drug Designation may Provide Eagle Seven Years Market Exclusivity First Self Marketed Drug for Eagle with Shipments to begin Shortly WOODCLIFF LAKE, N.J.--(Heal...
Biopharmaceuticals, FDA
Eagle Pharmaceuticals, Ryanodex, dantrolene, malignant hyperthermia

Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen

Wed, 07/23/2014 - 12:59
Strengthens Leadership Position in Treatments for Hunter syndrome and Commitment to MPS II Patient Community LEXINGTON, Massachusetts, July 23, 2014 -- (Healthcare Sales & Marketing Network) -- Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty b...
Biopharmaceuticals, Neurology, Licensing
Shire plc, ArmaGen , AGT-182, enzyme replacement therapy, Hunter syndrome

Teleflex Signs New Agreement with Amerinet for Surgical Instruments

Wed, 07/23/2014 - 12:53
WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, has announced a new agreement with Amerinet, a national healthcare solutions organization, for a co...
Devices, Group Purchasing
Teleflex, Amerinet, Pilling, KMedic

Occlutech Wins Invalidation of St Jude Patent

Wed, 07/23/2014 - 12:48
JENA, Germany, July 23, 2014 -- (Healthcare Sales & Marketing Network) -- Occlutech, a leading European developer of minimally invasive implants for therapy in structural heart disease, today announced that it has successfully obtained a ruling by the U.K...
Devices, Interventional Cardiology, Litigation
Occlutech, St Jude, AGA Medical

Synlogic Secures $29.4 Million Series A Financing Led by Atlas Venture and New Enterprise Associates

Tue, 07/22/2014 - 13:44
First-in-class, proprietary synthetic biology platform leveraged for application across multiple diseases CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Synlogic, Inc., a biotechnology company focused on the development of therapeutic microbe...
Biopharmaceuticals, Venture Capital
Synlogic, microbial engineering

Teleflex Receives FDA Clearance for ARROW-Clark(TM) VectorFlow(TM) Chronic Hemodialysis Catheter

Tue, 07/22/2014 - 13:38
WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, has announced it has received FDA 510(k) clearance to market its ARROW-Clark™ VectorFlow™ Chronic H...
Devices, FDA
Teleflex, ARROW-Clark, VectorFlow, Hemodialysis Catheter

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong